Naloxone Hydrochloride 51662-1385
Product NDC
51662-1385- Manufacturer
- Hf Acquisition Co Llc, Dba Healthfirst
- Dosage Form
- Injection, Solution
- Route
- Intramuscular, Intravenous, And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 15, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA070257
Need to source Naloxone Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Naloxone Hydrochloride | .4 mg/mL |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]
Packaging Options(1)
1 VIAL, MULTI-DOSE in 1 CARTON (51662-1385-1) / 10 mL in 1 VIAL, MULTI-DOSE